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Syphilis Hepatitis Presenting as a Mimic of Primary
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ABSTRACT
Syphilis hepatitis is a rare cause of acute liver injury. Primary biliary cholangitis (PBC) is a progressive autoimmune disease
characterized by the typical presentation of a cholestatic liver injury and the presence of antimitochondrial antibodies (AMAs). We
present a case of syphilis hepatitis that presented as a mimic to PBC with positive AMA. The eradication of syphilis led to the
resolution of the liver injury and down trending of the antibody level. We recommend excluding syphilis in patients with high-risk
behaviors presenting with a cholestatic liver injury and positive AMA before the diagnosis of PBC.
INTRODUCTION
Primary biliary cholangitis (PBC) is a progressive cholestatic liver disease defined by autoimmune destruction of intrahepatic bile
ducts.1 PBC most commonly affects middle-aged women and can progress to end-stage liver disease.2 The typical presentation is a
cholestatic liver injury pattern, marked by elevated alkaline phosphatase (ALP), gamma-glutamyltransferase, and total bilirubin.
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels are commonly normal or only moderately elevated.3
Antimitochondrial antibody (AMA) is present in 95%of PBCdiagnoses. Diagnostic criteria for PBC aremet with the combination of
an elevated AMA and ALP greater than 1.5 times the upper limit of normal.1
Syphilis is a sexually transmitted infectious disease caused by the spirochete, Treponema pallidum.4 The highest risk populations are
men who have sex with men and persons living with human immunodeficiency virus.5 The staged progression of syphilis is well-
documented. Primary syphilis manifests with a genital chancre, while secondary syphilis is characterized by the typical rash, fever,
and adenopathy.6 Syphilis hepatitis is a variation that is sparingly seen in secondary syphilis; although rare, it is more common in
persons living with human immunodeficiency virus (PLWH).5 We present a case of syphilis hepatitis that initially presented as a
mimic of PBC, with a cholestatic liver injury and a positive anti-M2 AMA level.
CASE REPORT
A 54-year-old man with medical history of human immunodeficiency virus, hypertension, hyperlipidemia, and diabetes mellitus
with a previous cholecystectomy presented to the emergency department with 1 week of diffuse abdominal pain and vomiting. On
arrival, the patient was afebrile and hypertensive. Additional signs and symptoms at the time of initial presentation included
jaundice, scleral icterus, and a diffuse nonpruritic erythematous, macular rash located on his torso, back, and extremities, including
palms. The rash emerged 3–4 days before presentation. Physical examinationwas negative for ascites, asterixis, hepatosplenomegaly,
lymphadenopathy, or genital lesions. Social history was pertinent for unprotected sex 6 months before presentation. He denied
recent travel or use of herbal supplements. Laboratory results showed K 5.6 mmol/L, Na 133 mmol/L, Cr 1.56 mg/dL, AST 91 IU/L,
ALT 120 IU/L, ALP 832 IU/L, total bilirubin 6.4 mg/dL, conjugated bilirubin 4.9 mg/dL, and CD4 count 336. Viral hepatitis panel
was negative. Hemogram did not show leukocytosis or thrombocytopenia. Through chart review, the patient did not have any
abnormal liver enzymes in the previous 5 years. Computed topography performed showed no acute abdominal abnormalities, no
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evidence of biliary obstruction. To further evaluate liver pa-
renchyma and the biliary system, a right upper quadrant ul-
trasound with Doppler was ordered. It demonstrated a
heterogenous, coarse liver with patent vascular, no spleno-
megaly, and an absent gallbladder. Common bile duct mea-
sured 2–3 mm. The patient’s acute kidney injury resolved with
intravenous fluids, but the acute cholestatic liver injury per-
sisted without evidence of worsening hepatic dysfunction. At
this point, the liver injury was felt to be secondary to his anti-
retroviral therapy regimen. Dolutegravir, abacavir, and lam-
ivudine were discontinued, and he was started on the
combination regimen bictegravir, emtricitabine, and tenofovir.
He was discharged home with plans for follow-up with primary
care provider in 1 week.
He presented 1 week later to his primary care provider with
continuous abdominal pain, jaundice, and diffuse rash. Labo-
ratory results showed persistent cholestatic liver injury AST
92 IU/L, ALT 144 IU/L, ALP 754 IU/L, and total bilirubin
6.7 mg/dL. Further testing obtained at this time was significant
for a positive syphilis immunoglobulin (Ig)G and rapid plasma
regain of 1:256 and an anti-M2 AMA IgG of 83.5 U (positive
.25 U) which was suspicious for syphilis hepatitis vs un-
derlying PBC. As he had an allergy to penicillin, he was started
on doxycycline for 2 weeks for the treatment of secondary
syphilis. He completed the antibiotic course with resolution of
abdominal pain, jaundice, and rash. Repeat laboratory work
obtained 2 months later revealed normalized liver function.
Once the rapid plasma regain titer returned negative, a repeat
AMA IgG was tested and negative at 16.4U. Liver biopsy was
not pursued because of resolution of the liver injury. Normal-
ization of both AMA IgG level and liver enzymes after eradi-
cation of syphilis prompted the diagnosis of syphilis hepatitis
associated with a false-positive AMA IgG level.
DISCUSSION
The incidence of syphilis hepatitis is variable, particularly in
PLWH. One retrospective analysis by Crum-Cianflone et al of
32 PLWH with early syphilis found hepatic involvement to be
38%.6 A second retrospective study found a lower rate of
syphilis hepatitis in PLWH 5/50 (10%); however, it was hy-
pothesized that there may have been an underestimation be-
cause of exclusion of patients with previous underlying liver
conditions.7 The diagnostic criteria for syphilis hepatitis
established byMullick et al: (i) abnormal liver enzyme levels; (ii)
serologic evidence for syphilis; (iii) exclusion of other causes of
liver diseases; and (iv) liver enzyme levels returning to normal
after appropriate antimicrobial treatment.8
Clinical manifestations of syphilitic hepatitis are often non-
specific. The most common signs are jaundice and a non-
pruritic rash with multiple erythematous and nonconfluent
maculopapular lesions, concentrated on the trunk, palms, and
soles.4,9 Serum liver transaminases are typically mildly in-
creased; however, the most common abnormality is a
disproportionately elevated serum ALP.8,10 This case simi-
larly presented with the characteristic rash and significantly
elevated ALP compared with other hepatic enzymes. The
highlight of this case is that the patient had an elevated anti-
M2 AMA titer that is normally associated with PBC, thus
complicating the initial diagnosis. Miyakawa et al previously
demonstrated that false-positive reactions to the PBC-specific
anti-M2 AMA reactions could occur with hepatitis A, syph-
ilis, and rheumatoid arthritis.11 This study showed a return to
a negative AMA titer after recovery from hepatitis A. How-
ever, such data after treatment for syphilis was not reported.
Similarly, syphilis has previously been described to cause an
elevation in other nonspecific mitochondrial antibodies
(particularly anti-M1 AMA) but not anti-M2 AMA.12,13
Although our patient initially met criteria for the diagnosis of
PBC, it is now apparent that the AMAwas elevated because of
an active syphilis infection. This is further supported by the
resolution of liver injury in this patient after treatment with
doxycycline. This case demonstrates the ability of syphilis to
cause positive anti-M2 AMA that are typically associated
with the diagnosis of PBC. As syphilis is an easily targeted
cause of liver injury, we recommend testing for syphilis in
patients with high-risk behaviors that present with a chole-
static liver injury and positive AMA before the diagnosis
of PBC.
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